Trinity Biotech plc (ADR) (NASDAQ:TRIB)

CAPS Rating: 5 out of 5

The Company develops, acquires, manufactures and markets medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market.

Recs

0
Player Avatar MFSean (< 20) Submitted: 9/1/2006 3:55:20 PM : Outperform Start Price: $8.07 TRIB Score: +30.78

New acquesitions will lead to improved growth earning - stock is now under valued - company in a strong position

Featured Broker Partners


Advertisement